No connection

Search Results

BCBP

BEARISH
$7.86 Live
BCB Bancorp, Inc. · NASDAQ
Target $9.5 (+20.9%)
$7.41 52W Range $12.26

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 24, 2026
Market cap
$135.41M
P/E
131.0
ROE
0.9%
Profit margin
4.3%
Debt/Equity
N/A
Dividend yield
8.02%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
BCBP exhibits weak financial health with a Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score to confirm safety from distress. The stock trades at a significant premium to its Graham Number of $4.79, currently priced at $7.86, despite deteriorating fundamentals including negative earnings and revenue growth. Profitability metrics like ROE (0.86%) and ROA (0.08%) are extremely weak, while the dividend is unsustainable with a payout ratio exceeding 1000%. Although analysts recommend a 'buy' with a $9.50 target, the company's track record of earnings misses and declining performance raises serious concerns.

Key Strengths

High dividend yield of 8.02% may attract income-seeking investors
Price/Book ratio of 0.46 suggests potential asset-based downside protection
Forward P/E of 7.97 is below sector average, implying possible earnings recovery expectations
Recent Q/Q EPS growth of +22.2% shows short-term improvement
Analyst recommendation is 'buy' with upside potential to $9.50

Key Risks

Piotroski F-Score of 4 indicates weak financial health and elevated risk
Extremely high payout ratio (1066.67%) threatens dividend sustainability
Earnings growth down 39% YoY with volatile and declining trend
Revenue declining YoY (-3.90%) and inconsistent operating performance
Technical trend score of 0/100 signals strong bearish momentum
AI Fair Value Estimate
Based on comprehensive analysis
$4.79
-39.1% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
33
Weak
Value
42
Future
35
Past
30
Health
32
Dividend
28
AI Verdict
High risk, low quality, overvalued
Key drivers: Low Piotroski score, Unsustainable dividend, Negative growth trends, Overvaluation relative to Graham Number, Poor earnings surprise history
Confidence
88%
Value
42/100

Ref P/E, PEG, Graham Number

Positives
  • Forward P/E of 7.97 is low
  • P/B of 0.46 suggests asset coverage
Watchpoints
  • Current P/E of 131.00 is extremely high
  • Stock trades at 64% above Graham Number ($7.86 vs $4.79)
Future
35/100

Ref Growth rates

Positives
  • Q/Q EPS growth turned positive (+22.2%)
Watchpoints
  • YoY earnings down 39%
  • Revenue growth negative (-3.90%)
  • PEG ratio unavailable due to instability
Past
30/100

Ref Historical trends

Positives
  • Some past earnings beats (e.g., +307.6% in 2020)
Watchpoints
  • Last 4 quarters beat only once
  • Average earnings surprise of -109.6%
  • Consistent downward trend in EPS
Health
32/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • No reported debt (though D/E is N/A)
Watchpoints
  • Piotroski F-Score of 4/9 indicates weak financial health
  • ROE of 0.86% and ROA of 0.08% are critically low
  • Altman Z-Score not available, increasing uncertainty
Dividend
28/100

Ref Yield, Payout

Positives
  • High yield of 8.02%
Watchpoints
  • Payout ratio of 1066.67% is unsustainable
  • Dividend strength score of 40/100 indicates high risk

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$7.86
Analyst Target
$9.5
Upside/Downside
+20.9%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for BCBP and closest competitors.

Updated 2026-01-23
BCB
BCB Bancorp, Inc.
Primary
5Y
-14.4%
3Y
-47.9%
1Y
-27.2%
6M
-4.7%
1M
-5.0%
1W
+2.1%
SCP
Social Commerce Partners Corporation
Peer
5Y
0.0%
3Y
0.0%
1Y
0.0%
6M
0.0%
1M
+0.1%
1W
+0.1%
GRX
The Gabelli Healthcare & Wellness Trust
Peer
5Y
-2.9%
3Y
+7.6%
1Y
+2.6%
6M
+2.6%
1M
+1.8%
1W
-0.4%
HYI
Western Asset High Yield Opportunity Fund Inc.
Peer
5Y
+12.4%
3Y
+25.7%
1Y
+3.9%
6M
-0.4%
1M
+4.5%
1W
-0.7%
BCV
Bancroft Fund Ltd.
Peer
5Y
+16.5%
3Y
+78.7%
1Y
+56.1%
6M
+8.4%
1M
+8.0%
1W
+0.5%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
131.0
Forward P/E
7.97
PEG Ratio
N/A
P/B Ratio
0.46
P/S Ratio
2.1
EV/Revenue
3.81
EV/EBITDA
N/A
Market Cap
$135.41M

Profitability

Profit margins and return metrics

Profit Margin 4.29%
Operating Margin 30.34%
Gross Margin N/A
ROE 0.86%
ROA 0.08%

Growth

Revenue and earnings growth rates

Revenue Growth -3.9%
Earnings Growth -39.0%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth -36.1%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$14.53

Quarterly Earnings History

EPS performance vs analyst estimates

2026-01-30
$N/A
2025-10-27
$0.22
+3.1% surprise
2025-07-28
$0.18
-3.6% surprise
2025-04-22
$-0.51
-328.4% surprise

Financial Services Sector Comparison

Comparing BCBP against 820 companies in the Financial Services sector (141 bullish, 351 neutral, 328 bearish)
P/E Ratio
131.0
This Stock
vs
36.01
Sector Avg
+263.8% (Expensive)
Return on Equity (ROE)
0.86%
This Stock
vs
-0.73%
Sector Avg
-217.1% (Below Avg)
Profit Margin
4.29%
This Stock
vs
91.62%
Sector Avg
-95.3% (Weaker)
Revenue Growth
-3.9%
This Stock
vs
35.27%
Sector Avg
-111.1% (Slower)

Similar Companies

Peer comparison within the same industry

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
3 analysts
Keefe, Bruyette & Woods
2025-10-28
Maintains
Market Perform Market Perform
Piper Sandler
2025-07-30
Maintains
Neutral Neutral
Keefe, Bruyette & Woods
2025-07-29
Maintains
Market Perform Market Perform

Past News Coverage

Recent headlines mentioning BCBP from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile